June 15 (Reuters) - Allergan (NYSE:AGN_pa) Plc AGN.N :
* "Look forward to working together with FDA" to bring
glaucoma treatment system to market
* Allergan announces FDA acceptance of the 510(k) premarket
notification filing for the XEN glaucoma treatment system
Source text for Eikon:
Further company coverage: AGN.N
(Bengaluru Newsroom: +1-646-223-8780)